Mark J. Evans
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Immunology top 5%
- Complement system in diseases
Papers in
-
- Mitochondrial Function and Pathology 6
- RNA Interference and Gene Delivery 5
- Oncology 26
- Drug Transport and Resistance Mechanisms 11
- Cancer Cells and Metastasis 6
- Co-authors
- Richard C. Scarpulla (7 shared papers)KehDih Lai (9 shared papers)Douglas C. Harnish (9 shared papers)C. J. Kovacs (26 shared papers)Helen B. Hartman (6 shared papers)Louis A. Matis (5 shared papers)Russell P. Rother (5 shared papers)Stephen P. Squinto (4 shared papers)
- Journals
- Endocrinology (5 papers)Cell Proliferation (5 papers)Journal of Biological Chemistry (5 papers)Journal of Lipid Research (3 papers)Molecular Immunology (3 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Mark J. Evans
79 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 112
- Oncology 665
- Immunology 530
- Molecular Biology 1.5k
- Cancer Research 263
- Hematology 188
Countries citing papers authored by Mark J. Evans
This map shows the geographic impact of Mark J. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Evans more than expected).
Fields of papers citing papers by Mark J. Evans
This network shows the impact of papers produced by Mark J. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Evans. The network helps show where Mark J. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 372 | |
| 2 | 1996 | 300 | |
| 3 | 1989 | 235 | |
| 4 | 1994 | 181 | |
| 5 | 2001 | 142 | |
| 6 | 2009 | 125 | |
| 7 | 1992 | 115 | |
| 8 | 2003 | 95 | |
| 9 | 2009 | 86 | |
| 10 | 2009 | 81 | |
| 11 | 1998 | 78 | |
| 12 | 1988 | 78 | |
| 13 | 2006 | 74 | |
| 14 | 2003 | 73 | |
| 15 | 2001 | 69 | |
| 16 | 2002 | 67 | |
| 17 | 2002 | 49 | |
| 18 | 2010 | 46 | |
| 19 | 1992 | 44 | |
| 20 | 1988 | 44 |
About Mark J. Evans
Mark J. Evans is a scholar working on Molecular Biology, Oncology, Surgery, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 80 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (13 papers), Drug Transport and Resistance Mechanisms (11 papers), Estrogen and related hormone effects (9 papers), Effects of Radiation Exposure (9 papers), Hematopoietic Stem Cell Transplantation (6 papers), Cancer Cells and Metastasis (6 papers), Mitochondrial Function and Pathology (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Oncology (665 citations), Immunology (530 citations), Molecular Biology (1.5k citations), Cancer Research (263 citations) and Hematology (188 citations). Mark J. Evans has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Richard C. Scarpulla, KehDih Lai, Douglas C. Harnish, C. J. Kovacs, Helen B. Hartman, Louis A. Matis, Russell P. Rother, Stephen P. Squinto, Scott A. Rollins and Eileen A. Elliott. Their work appears in journals such as Endocrinology, Cell Proliferation, Journal of Biological Chemistry, Journal of Lipid Research and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.